Swedish Healthtech Stock News

OM:ALFA
OM:ALFAMachinery

Is It Time To Reassess Alfa Laval (OM:ALFA) After Its Recent Share Price Pullback?

If you are wondering whether Alfa Laval stock is still reasonably priced after its recent run, looking closely at its current valuation can help you decide how it fits into your portfolio. The share price closed at SEK 511.20, with returns of 9.1% year to date and 29.2% over the past year, even though the stock has fallen 7.3% in the last week and 6.7% over the past month. Recent news coverage has focused on Alfa Laval as a well followed industrial stock in Sweden, often highlighting how...
OM:SAAB B
OM:SAAB BAerospace & Defense

Assessing Saab (OM:SAAB B) Valuation After Major Defence Orders And Canada AEW Negotiations

Saab (OM:SAAB B) is back in focus after Canada moved into formal negotiations, naming GlobalEye as its preferred solution for a new Airborne Early Warning and Control program, alongside multiple recent defence contracts and partnerships. See our latest analysis for Saab. The stock has pulled back recently, with a 1-day share price return of 5.81% down, a 30-day share price return of 4.25% down and a 90-day share price return of 16.77% down. This comes while the 1-year total shareholder return...
OM:NIBE B
OM:NIBE BBuilding

Assessing NIBE Industrier (OM:NIBE B) Valuation After Improved Earnings And Board Appointment

Earnings context and what changed at NIBE Industrier NIBE Industrier (OM:NIBE B) has just reported first quarter 2026 earnings, with net income and basic earnings per share higher than a year earlier, while sales stayed close to prior year levels. At the same time, the Annual General Meeting on May 19 elected Henrik Elmin to the board. This gives you two fresh data points to consider – profitability and governance – when assessing the stock. See our latest analysis for NIBE Industrier. The...
OM:GETI B
OM:GETI BMedical Equipment

Assessing Getinge (OM:GETI B) Valuation After Recent Choppy Share Price Performance

Recent performance snapshot for Getinge (OM:GETI B) With no single headline event driving attention, Getinge (OM:GETI B) has still given investors a mixed recent experience, combining short term share price swings with solid headline revenue and net income figures in Swedish kronor. See our latest analysis for Getinge. Recent trading has been choppy, with the 1 day share price return of 0.72% and 30 day share price return of 3.43% set against a year to date share price decline of 12.75% and a...
OM:SINCH
OM:SINCHSoftware

Assessing Sinch (OM:SINCH) Valuation After Strong Recent Share Price Momentum

Sinch (OM:SINCH) has drawn investor attention after recent share price moves, with the stock showing double digit returns over the past month and the past 3 months, prompting a closer look at its current valuation. See our latest analysis for Sinch. At a share price of SEK39.58, Sinch has seen strong share price momentum, with a 37.48% 1 month share price return and a 79.34% 3 month share price return, alongside a 56.32% 1 year total shareholder return that contrasts with a much weaker 5 year...
OM:VOLCAR B
OM:VOLCAR BAuto

A Look At Volvo Cars (OM:VOLCAR B) Valuation After Recent Share Price Gains

Event recap and recent share performance Volvo Car AB (publ.) (OM:VOLCAR B) has attracted investor attention after a recent stretch in which the stock gained about 1% over the past day, 2% over the past week, and roughly 10% over the past month. See our latest analysis for Volvo Car AB (publ.). That recent 9.7% 30 day share price return sits against a year to date share price decline of 27%. The 1 year total shareholder return of 40.9% shows how sentiment has swung over a longer window. If...
OM:MORROW
OM:MORROWBanks

June 2026 European Value Stocks Trading Below Estimated Worth

The European market has experienced modest gains recently, with the STOXX Europe 600 Index rising slightly amid investor optimism surrounding potential U.S.-Iran agreements that could stabilize energy prices. Despite some volatility from an MSCI EMEA Index rebalancing, major indices like Germany's DAX and France's CAC 40 have shown positive movement. In this environment, identifying stocks trading below their estimated worth can provide opportunities for investors seeking value in a market...
OM:BIOA B
OM:BIOA BBiotechs

BioArctic (OM:BIOA B) Valuation Check After AGM Dividend Approval And New Employee Incentive Plan

BioArctic (OM:BIOA B) has come into focus after its recent Annual General Meeting, where shareholders approved a SEK 2 per share dividend, adopted the financial statements, and backed a new three year employee incentive program. See our latest analysis for BioArctic. Those AGM decisions come after a strong run in the shares, with a 90 day share price return of 21.52% and a 1 year total shareholder return of 93.29%, suggesting momentum has been building around BioArctic despite the recent Q1...
OM:WALL B
OM:WALL BReal Estate

Wallenstam (OM:WALL B) Valuation Check After Mullvad Lease Brings Gothenburg Property To Full Occupancy

Lease agreement with Mullvad VPN puts spotlight on Wallenstam Wallenstam (OM:WALL B) has secured a lease with Mullvad VPN AB for the remaining 4,567 square meters of office space in its Valvet property in Gothenburg, bringing the 8,500 square meter building to full occupancy. See our latest analysis for Wallenstam. The Mullvad lease comes as Wallenstam’s short term share price return over the last month is up 2.91%, while the 1 year total shareholder return is down 13.91%. This may hint that...
OM:SHOT
OM:SHOTHospitality

Scandic Hotels Group (OM:SHOT) Valuation Check After Mixed Short Term Moves And Strong 1 Year Returns

Scandic Hotels Group: Recent Moves in Context Scandic Hotels Group (OM:SHOT) has drawn attention after recent share price moves, with the stock showing mixed short term returns and a stronger pattern over the past 3 months and year. At a last close of SEK 90.75, the company’s market value stands near SEK 19.5b, supported by reported revenue of SEK 22,432m and net income of SEK 644m across its Nordic and wider European hotel operations. See our latest analysis for Scandic Hotels Group. Recent...
OM:ERIC B
OM:ERIC BCommunications

Assessing Ericsson (OM:ERIC B) Valuation After New Maritime 4G 5G And AI Partnership With Net Feasa

Telefonaktiebolaget LM Ericsson (OM:ERIC B) has entered a new global partnership with IoT provider Net Feasa to expand its 4G and 5G connectivity and AI-driven data management into the maritime supply chain. See our latest analysis for Telefonaktiebolaget LM Ericsson. The new maritime IoT partnership comes after a period of strong market interest, with a 30 day share price return of 10.84% and a year to date share price return of 36.01%. At the same time, total shareholder return of 52.30%...
OM:SSAB A
OM:SSAB AMetals and Mining

A Look At SSAB (OM:SSAB A) Valuation After SEK 3,300 Million Oxelösund Expansion Decision

Why SSAB’s new Oxelösund investment matters for shareholders SSAB (OM:SSAB A) has approved a SEK 3,300 million investment in a new quenching and tempering line in Oxelösund, with the aim of increasing capacity in advanced wear and protection steels such as Hardox 500Tuf and Armox. See our latest analysis for SSAB. That Oxelösund expansion comes as momentum in the stock has been firm, with a 30 day share price return of 15.57% and a 1 year total shareholder return of 69.08% pointing to...
OM:PEAB B
OM:PEAB BConstruction

Peab (OM:PEAB B) Valuation Check After New €11 Million Finnish Renovation Contract

Peab (OM:PEAB B) has secured an €11 million contract to fully renovate Iisalmi’s heritage-listed multifunction center in Finland, adding a visible public sector project to its Construction order book. See our latest analysis for Peab. At a share price of SEK90.8, Peab has seen its 1 year total shareholder return of 14.54% and very strong 3 year total shareholder return of 111.76% contrast with a 90 day share price return that is down 14.66%. This suggests longer term momentum remains solid...
OM:SOBI
OM:SOBIBiotechs

Tryngolza Data Sharpens Swedish Orphan Biovitrum Severe Hypertriglyceridemia Story

Swedish Orphan Biovitrum (OM:SOBI) reported new Phase 3 data for Tryngolza (olezarsen) in severe hypertriglyceridemia at EAS 2026. The analysis showed an 85% reduction in acute pancreatitis events in treated patients. Tryngolza also produced substantial triglyceride lowering in a large, difficult to treat population. The results add fresh detail to earlier regulatory milestones and expand visibility on efficacy and safety. Swedish Orphan Biovitrum (OM:SOBI) focuses on rare diseases, and...
OM:BILI A
OM:BILI ASpecialty Retail

Assessing Bilia (OM:BILI A) Valuation After Kia Sweden Deal Stronger Q1 Earnings And Dividend Payment

Bilia (OM:BILI A) recently signed a new agreement with Kia Sweden, alongside reporting stronger Q1 earnings and paying dividends. This combination has drawn fresh attention to the stock from investors. See our latest analysis for Bilia. At a share price of SEK141.3, the stock has gained momentum recently, with a 12.5% 1 month share price return and a 90 day share price return of 10.48%. The 3 year total shareholder return of 56.52% points to a stronger longer term record. If you are looking...
OM:TEL2 B
OM:TEL2 BWireless Telecom

A Look At Tele2 (OM:TEL2 B) Valuation After Dividend Approval And AGM Decisions

AGM decisions and why they matter for Tele2 (OM:TEL2 B) shareholders Tele2 (OM:TEL2 B) just wrapped up its 18 May 2026 Annual General Meeting, where shareholders approved a SEK 10.50 per share ordinary dividend for 2025, refreshed the Board, and allowed reclassification of Class A shares into Class B shares. See our latest analysis for Tele2. Tele2's share price has eased in the short term, with a 1-day share price return showing a 0.55% decline and a 30-day share price return down 8.52%...
OM:SWED A
OM:SWED ABanks

Assessing Swedbank (OM:SWED A) Valuation After Mixed Share Performance And Conflicting Fair Value Signals

Swedbank’s recent share performance in focus Swedbank (OM:SWED A) is back on many investors’ watchlists after recent share price moves, with the stock up about 5.6% over the past month but slightly weaker over the past 3 months. This comes against a backdrop of steady full year figures, including revenue of SEK 68,207,000,000 and net income of SEK 31,911,000,000. These figures help frame how the bank’s current market value of roughly SEK 383.6b is being weighed. See our latest analysis for...
OM:ERIC B
OM:ERIC BCommunications

Is Ericsson (OM:ERIC B) Fairly Priced After Strong 12-Month Share Price Performance?

If you are wondering whether Telefonaktiebolaget LM Ericsson is priced attractively right now, the key question is how its current share price compares to a grounded view of fair value. The stock last closed at SEK 120.10, after a week where it declined 4.6%. It is still up 12.8% over the past month, 36.0% year to date and 52.3% over the past year, with a 3 year return of 138.8% and a 5 year return of 32.7%. Recent share price moves have been set against ongoing attention on Ericsson's role...